These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20222138)

  • 1. Two Parkinson's disease patients with alpha-synuclein gene duplication and rapid cognitive decline.
    Shin CW; Kim HJ; Park SS; Kim SY; Kim JY; Jeon BS
    Mov Disord; 2010 May; 25(7):957-9. PubMed ID: 20222138
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Brueggemann N; Odin P; Gruenewald A; Tadic V; Hagenah J; Seidel G; Lohmann K; Klein C; Djarmati A
    Neurology; 2008 Oct; 71(16):1294; author reply 1294. PubMed ID: 18852448
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning.
    Kéri S; Nagy H; Myers CE; Benedek G; Shohamy D; Gluck MA
    Genes Brain Behav; 2008 Feb; 7(1):31-6. PubMed ID: 17451452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive rehabilitation in Parkinson's disease.
    Sinforiani E; Banchieri L; Zucchella C; Pacchetti C; Sandrini G
    Arch Gerontol Geriatr Suppl; 2004; (9):387-91. PubMed ID: 15207437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
    Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
    Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication.
    Orimo S; Uchihara T; Nakamura A; Mori F; Ikeuchi T; Onodera O; Nishizawa M; Ishikawa A; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2008 Nov; 116(5):575-7. PubMed ID: 18751989
    [No Abstract]   [Full Text] [Related]  

  • 8. Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).
    Somme JH; Gomez-Esteban JC; Molano A; Tijero B; Lezcano E; Zarranz JJ
    J Neurol Sci; 2011 Nov; 310(1-2):86-9. PubMed ID: 21880335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Troiano AR; Cazeneuve C; Le Ber I; Bonnet AM; Lesage S; Brice A
    Neurology; 2008 Oct; 71(16):1295; author reply 1295. PubMed ID: 18852449
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.
    Ikeuchi T; Kakita A; Shiga A; Kasuga K; Kaneko H; Tan CF; Idezuka J; Wakabayashi K; Onodera O; Iwatsubo T; Nishizawa M; Takahashi H; Ishikawa A
    Arch Neurol; 2008 Apr; 65(4):514-9. PubMed ID: 18413475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease.
    Deng H; Xie W; Guo Y; Le W; Jankovic J
    Mov Disord; 2006 May; 21(5):728-9. PubMed ID: 16552756
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
    Berg D; Niwar M; Maass S; Zimprich A; Möller JC; Wuellner U; Schmitz-Hübsch T; Klein C; Tan EK; Schöls L; Marsh L; Dawson TM; Janetzky B; Müller T; Woitalla D; Kostic V; Pramstaller PP; Oertel WH; Bauer P; Krueger R; Gasser T; Riess O
    Mov Disord; 2005 Sep; 20(9):1191-4. PubMed ID: 15895422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson's disease.
    Sławek J; Wieczorek D; Derejko M; Dubaniewicz M; Brockhuis B; Sitek E; Wilczewska L; Roszmann A; Lass P
    Parkinsonism Relat Disord; 2010 Jan; 16(1):73-4; author reply 75-6. PubMed ID: 19682944
    [No Abstract]   [Full Text] [Related]  

  • 14. Implicit category learning performance predicts rate of cognitive decline in nondemented patients with Parkinson's disease.
    Filoteo JV; Maddox WT; Salmon DP; Song DD
    Neuropsychology; 2007 Mar; 21(2):183-92. PubMed ID: 17402818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay discounting of reward and caudate nucleus volume in individuals with α-synuclein gene duplication before and after the development of Parkinson's disease.
    Szamosi A; Nagy H; Kéri S
    Neurodegener Dis; 2013; 11(2):72-8. PubMed ID: 23038403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years.
    Morgante L; Basile G; Epifanio A; Spina E; Antonini A; Stocchi F; Di Rosa E; Martino G; Marconi R; La Spina P; Nicita-Mauro V; Di Rosa AE
    Arch Gerontol Geriatr Suppl; 2004; (9):291-6. PubMed ID: 15207426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
    Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
    Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noun verb dissociation in Parkinson's disease.
    Bertella L; Albani G; Greco E; Priano L; Mauro A; Marchi S; Bulla D; Semenza C
    Brain Cogn; 2002; 48(2-3):277-80. PubMed ID: 12030451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.